Policy | June 17, 2023
Health Ministry to prepare National Action Plan on AMR 2.0
Convergent action on AMR identified as an important area of intervention
Convergent action on AMR identified as an important area of intervention
Acquisition delivers industry-leading research capability, and strengthens pipeline with a novel candidate for ulcerative colitis, Crohn’s disease and other autoimmune conditions
Urges Innovators to produce quality products that can be deployed at scale
The inspection closed with zero observations
The company has now received the Establishment Inspection Report (EIR) indicating closure of the inspection
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
The new range of HDPE bottles is compliant with US FDA, EU regulations and Chinese DMF registration for use in dry pharmaceutical applications
Granules now has a total of 58 ANDA approvals from US FDA
Subscribe To Our Newsletter & Stay Updated
